HC Wainwright Issues Negative Estimate for JANX Earnings
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Investment analysts at HC Wainwright lowered their Q1 2025 earnings estimates for Janux Therapeutics in a research note issued on Monday, March 3rd. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings of ($0.48) per share for the quarter, down from their previous […]
Janux Therapeutics, Inc. (NASDAQ:JANX – Free Report) – Investment analysts at HC Wainwright lowered their Q1 2025 earnings estimates for Janux Therapeutics in a research note issued on Monday, March 3rd. HC Wainwright analyst S. Ramakanth now anticipates that the company will post earnings of ($0.48) per share for the quarter, down from their previous […]
